Mounjaro (Tirzepatide) Explained
What makes tirzepatide different, how dosing typically progresses, and who it is generally considered for.
Mounjaro (tirzepatide) is the newest of the three medicines patients ask us about most, and the one with the most confusion around dosing. Here is what makes it different, stated plainly.
What makes tirzepatide different
Most GLP-1 medicines act on a single receptor. Tirzepatide acts on two — GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). The combination is why it is often associated with a stronger effect on both appetite and blood sugar than single-receptor medicines, though individual response varies considerably.
A prefilled pen, once weeklyDosing is self-administered after training at your first appointment — no repeat clinic visits needed just to inject.How dosing typically progresses
Treatment starts at the lowest available strength and is raised in stages, spaced roughly a month apart, and only if the current dose is well tolerated. Your prescriber sets the actual schedule against your response — this is the shape of it, not a fixed timetable.
- 01Starting doseThe lowest strength, to let your body adjust with minimal side effects.
- 02Early increasesRaised in the first couple of months if tolerated well.
- 03Maintenance rangeMost patients settle at a dose that balances effect against side effects.
- 04Ongoing reviewDose can be held, raised or reduced at any monthly review — it is not one-way.
Side effects specific to tirzepatide
The pattern is similar to other GLP-1 medicines — nausea, reduced appetite, constipation and occasional reflux, most pronounced around each dose increase. Because it acts on two receptors, some patients notice effects slightly earlier in the dose range than with single-receptor medicines, though this varies.
Not interchangeable with other GLP-1 medicines
Switching between tirzepatide, semaglutide (Wegovy, Ozempic) or another agent is a clinical decision, not a straightforward substitution. Doses do not translate directly between them.
Who it is generally considered for
The same broad eligibility applies as for other GLP-1 medicines — BMI thresholds with or without related conditions such as type 2 diabetes, hypertension or fatty liver. Your specific suitability, including any contraindications, is confirmed at consultation.
Ready to talk it through?
This article is general information. Whether it applies to you is a five-minute conversation, not a guess.
Mounjaro Guide, answered
Is tirzepatide stronger than semaglutide?
It works on an additional receptor and is often associated with a greater average effect in trials, but individual response varies and "stronger" does not mean "right for you" without an assessment.
How often is Mounjaro injected?
Once weekly, on the same day each week, with or without food.
What if I miss a dose?
There is a window within which a missed dose can still be taken — ask your prescriber for the specific guidance rather than guessing.
Can I take it alongside metformin or insulin?
Often yes, but insulin and sulfonylurea doses frequently need adjusting to avoid low blood sugar. Bring your full medication list to your assessment.
How long do people typically stay on it?
It varies. Some continue long term, others taper with a maintenance plan. This is reviewed at every follow-up, not decided once.
Does The Prime Fit prescribe Mounjaro directly?
Eligibility and prescribing are confirmed at a medical consultation. We do not sell or dispense medication online.